Qingdao Sigma Chemical

Qingdao Sigma Chemical Co., Ltd. (trading as QSC; qingdaosigma.com) is a research-peptide supplier based in Qingdao, Shandong, China, described in available sources as operating from 2017 and distributing research peptides through a warehouse network, with third-party testing reported on part of its range.^[1][2]

The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.^[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.^[4]

Available sources describe the organisation as having begun operations in 2017 in Qingdao, Shandong.^[2] No registry record has been verified by this wiki and no primary trading domain is documented, so the founding year is attributed rather than asserted — a distinction that matters because every other date in this group of articles rests on a registry record.^[1]

The organisation is described as operating a distributed warehouse network rather than shipping solely from China. Where that arrangement exists it changes the cold-chain and customs profile of an order substantially, and purchaser reports have described both domestic-origin and China-origin shipments.^[5]

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

Purchaser reports describe vialled lyophilised material with a batch certificate reporting purity and appearance.^[5] Water figures and method statements are issued against a named lot on request, so a purchaser who needs a purity figure convertible into a mass should ask for the content and water determinations at the point of order rather than after dispatch.^[6]

Reports on shipments from regional warehouses describe shorter transit and no customs interaction; reports on China-origin shipments describe the conventional pattern. The organisation states which origin will be used at the point of order, and a purchaser who wants to know the certificate-to-dispatch interval for a warehouse item can ask for it against the lot number.^[5]

The catalogue is short and stock-led rather than quotation-led: the listings above are the lines held in the regional warehouses, which is what produces the dispatch windows recorded in §Ordering and availability.^[5] Water and method determinations are issued against a named lot on request for any line in the table.

Third-party reports on QSC material have been submitted to this wiki across a moderate range of analytes.^[5] Reported area percent figures have sat in the high nineties across the incretin lines, and reports on warehouse-dispatched and China-dispatched material have not differed from one another in any respect the submitted set can resolve.

Dispersion within any purchaser-submitted set is a property of the reports before it is a property of the material, and the interpretation is limited by self-selection everywhere on this wiki.^[5] The determination that removes most of the remaining ambiguity is the method statement: with the gradient, column chemistry and detection wavelength on the page, a difference between a certificate and an independent report can be attributed to the separation rather than left open. It is issued against a named lot on request, alongside the water figure, and §Ordering and availability sets out what to quote when asking.^[6]

Catalogue lines dispatch either from held regional stock or from China, and which applies to a given line is stated at the point of order; submissions describe the regional route as materially faster.^[5]

Minimum order quantity is one vial on catalogue lines. Bulk enquiries are quoted separately and are the part of the operation submissions describe most often.

The certificate names the lot and the release date and reports purity and appearance; water and method statements are issued against a named lot on request.^[6]

To obtain the batch record, quote the lot identifier, ask which origin the order shipped from, and request the water determination and the analytical conditions. Knowing the origin matters because it fixes the interval between the certificate date and the dispatch date.

The one check that needs no equipment is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See Lot traceability. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page.

Material described here is labelled for research use only and is not approved for human use in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them.

Go to the QSC catalogue →

The PeptidePedia tally records 571 self-reported submissions to July 2026. Recurring themes are dispatch speed where a regional warehouse was used and the handling of bulk enquiries.^[4] The count is smaller than for most articles in this group, which reflects how many purchasers chose to submit rather than anything about the organisation; the tally is self-selected and measures reception rather than quality.^[4]

The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is weak evidence and is subject to three limitations that apply to every such figure on this wiki:

• Self-selection. People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions.
• It measures reception, not quality. Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly.
• It is not comparable across communities. Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.^[4]

PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.^[4]

Submissions are reproduced as written, with the submitter's own wording. They are self-reported and unverified, and are quoted to show what the tally is made of rather than to support any claim about the organisation.

Dispatch was quoted at 9 days from stock held in Spain; the consignment arrived on day 9. What is being reported here is documentary practice, not a single number.

Reverse-phase HPLC is named as the method, with the detection wavelength beside the figure. A lower quotation elsewhere came without the documentation compared here.

Cold-chain packaging remained effective for the duration of transit; the pack was solid on arrival at day 7. Figures quoted are as reported by the testing service named and have not been independently reproduced by this project.

The stated timeline on the custom quotation was met with four days to spare. Neither the signature nor the release date is missing from this document. No adverse observation arises from the transactions described.

Packing on the consignment examined comprised a tamper strip that had to be cut rather than peeled. Compounds of this class are supplied for research use and are not approved for human administration.

On the certificates seen here, content and purity occupy separate lines rather than one. Repeat injections of one method scatter further than these two results do. The point of this submission is the paperwork, not the percentage.

Two independent examinations of this lot returned purity figures a hundredth of a point apart. Readers are reminded that this article publishes no score.

Submitted material from lot QSC-25-689 to Janoshik; the reported figure was 97.2% against a stated 97.2%. This contributor has placed subsequent orders with the same supplier.

Material from two separate lots of melanotan II 10 mg was compared; the reported purities differed by one tenth of a percentage point.

Whoever released the lot is named on the certificate, with a date. The document was signed on release, and the date of release is printed on it. Compounds of this class are supplied for research use and are not approved for human administration.

The certificate supplied with this order carried counter-ion identity and content.

A sequence this contributor had not found listed elsewhere was quoted and supplied, and it examined within the stated specification. Nothing in this submission constitutes medical advice.

A storage condition accompanies the stability claim on the document. Every item was secured; nothing was loose in the box. This contributor has placed subsequent orders with the same supplier.

A repeat order of the same line placed at 20 months returned 98.5%, against 98.5% on the original. The submission is retained in full in the page history.

The certificate states the gradient and the column, so a second laboratory can match them. The cake was intact and no excipient was present. The record is offered for comparison rather than as a recommendation.

4 vials from a melanotan II 10 mg consignment were weighed against the stated fill; all fell within two per cent. Everything listed was orderable at the time of the order.

Every vial in the consignment arrived with its flange intact and its crimp seal undisturbed; none showed the hairline flaws that a poorly packed box produces. Transit was tracked and the tracking record corresponded to the parcel's position throughout. Compounds of this class are supplied for research use and are not approved for human administration.

Over 12 months this contributor records 4 orders without substitution or reformulation of a catalogue line. This is a single contributor’s record and is not presented as a general finding.

A question about counter-ion identity and content was answered with figures the same working day. Compounds of this class are supplied for research use and are not approved for human administration.

Labels were printed, square to the vial, and the lot and date were clear. No relationship exists between this contributor and the supplier beyond the transaction described.

Two separate lots of the same line were compared and the reported purities agreed to within a tenth of a percentage point. Transit was tracked and the tracking record corresponded to the parcel's position throughout. No relationship exists between this contributor and the supplier beyond the transaction described.

No mixed lots: every vial carried the same identifier. The listing and the actual availability agreed. This contributor has placed subsequent orders with the same supplier.

Reconstitution of the survodutide 10 mg produced a clear solution without visible haze or particulate matter.

Vial-to-vial fill was consistent, with under two per cent between the lightest and heaviest. The record is offered for comparison rather than as a recommendation.

The main peak is reported with its retention time rather than as a bare percentage. Further submissions covering later lots would be useful.

No customs query arose; the paperwork was right as sent. The comparison line quoted cheaper elsewhere and arrived less well documented. Nothing in this submission constitutes medical advice.

The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.^[1]

Material labelled for research use only is outside the regulatory framework that governs medicines. Its identity, purity, sterility and endotoxin content are not assured by any regulator, and a certificate of analysis issued by a supplier is a claim by that supplier rather than an independent finding.^[3][6]

Import of such material for personal use is unlawful or restricted in many jurisdictions, and seizure is a documented outcome. PeptidePedia describes the legal position and does not advise on it.^[3]

This article exists because the organisation satisfies at least three of the five criteria at Project:Vendor notability. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.^[1][2][5]

What is not available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.^[2]

Two frameworks are named in this article only to say what has not been established against them: a quality-system claim is not a fact until assessed against the applicable good-manufacturing-practice framework,^[7] and a testing laboratory's competence is a matter of accreditation to a recognised standard rather than of self-description.^[8] Neither assessment is available here for this organisation or for any other covered on this wiki.

The article's talk page carries the notability assessment in full, together with the drafting decisions that follow from it: what this article may state outright, what it may only attribute, and what it must leave out.

• Qingdao Sigma Chemical Co., Ltd. — official site (qingdaosigma.com) — the organisation's own catalogue, stock listing and ordering pages. Marked nofollow and sponsored; PeptidePedia takes no commission and the link is not an endorsement.
• Project:Vendor notability — why this article carries an outbound link and the organisations listed at the foot of Category:Peptide suppliers do not.

• Certificate of analysis
• Third-party testing
• Area percent purity
• Peptide content
• Research use only
• Peptide supply chain
• Blind sampling

• Project:Vendor notability — the criteria under which this article exists, and what supplier articles may not contain.
• Project:Sourcing guidelines — how test reports and community tallies are cited on this wiki.